🏛️ Verified NIH Record • Updated 2025-01-10

A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL) (NCT05885464)

🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic Sponsor: Beam Therapeutics Inc.

🩺 Plain-English Summary (8th-Grade Level)

This is a Phase 1/2, multicenter, open-label study to evaluate the safety and efficacy of BEAM-201 in patients with relapsed/refractory T-ALL or T-LL. This study consists of Phase 1 dose-exploration cohorts, Phase 1 dose-expansion cohort(s), a Phase 1 pediatric cohort (will enroll patients ages 1 to \< 12 years), and a Phase 2 cohort.

Who can join: Review the eligibility criteria below.

Location: Stanford University School of Medicine — Stanford, California

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (10 Sites)

  • Stanford University School of Medicine — Stanford, California
  • Colorado Blood Cancer Institute — Denver, Colorado
  • University of Chicago — Chicago, Illinois
  • The University of Kansas Cancer Center — Fairway, Kansas
  • Dana Farber and Boston Children's Hospital — Boston, Massachusetts
  • Cleveland Clinic- Taussig Cancer Center — Cleveland, Ohio
  • OHSU Knight Cancer Institute Hematology Oncology — Portland, Oregon
  • Children's Hospital of Philadelphia — Philadelphia, Pennsylvania
  • Sarah Cannon- TriStar Bone Marrow Transplant — Nashville, Tennessee
  • Methodist Hospital - Texas Transplant Institute — San Antonio, Texas

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
🏛️ View Official NIH Record ↗